肝轉(zhuǎn)移瘤經(jīng)肝動(dòng)脈介入治療療效評(píng)價(jià)及影響因素分析.pdf

1、中國(guó)協(xié)和醫(yī)科大學(xué)碩士學(xué)位論文肝轉(zhuǎn)移瘤經(jīng)肝動(dòng)脈介入治療療效評(píng)價(jià)及影響因素分析姓名：閆東申請(qǐng)學(xué)位級(jí)別：碩士專業(yè)：影像醫(yī)學(xué)與核醫(yī)學(xué)指導(dǎo)教師：李槐20040501中國(guó)協(xié)和醫(yī)科大學(xué)中國(guó)醫(yī)學(xué)科學(xué)院碩士研究生畢業(yè)論文Evaluationofefficacyandprognosticfactorsinthepatientsoflivermetastasestreatedwithinterventionaltherapybyhepaticartery[A

2、bstract]ObjectiveToevaluatetheefficacyandvalueintheDatientsof1ivermetastasestreatedwithregionaltherapyofhepattcarteryinCox’SregressionmultivariateanalysesMethodsOf470patientSwithlivermetastasesweretreatedbyregionaltherap

3、yofhepaticarteryjn1231timesAntitumoragentswereselectedaccordingtothepathologicresultsoforigintumor，addedembolizationwith1ipiodolultra—fluid(LUF)or／andgelatinspongetothepatientsofhypervascularCoxregressionwasusedinproport

4、ionalhazardanalysisResponserateswereassessedbyCTscanResultsThemediansurvivalperiod(MS)of470patientswas135monthsAnoverallresponserate(CRPR)was504％The05一，10一，2O，30一，5Oyearsurvivalratewas86。4％、668％、356％、169％、73％respectively

5、TherewasnoseveresideeffectandeomplicationCoxregressionmultivariableanalysesshowedthattheMSofthepatientswithhypervascular、resectedoforigintumor、singlelesion、withouttumorthrombusinportalvein、adjuvantchemotherapyafterregion

6、altherapyofhepaticarteryandoriginatedfrombreastcancerwerelongerthantheothers(尸O01)，Thesurvivalperiodwas10ngerinthepatientsinvolvedofalobeof1iverandwithoutmetastasestotheothersites(PO05)ConclusionTheregionaltherapyofhepat

7、icarteryiSabetterwayforlivermetastasesThoseofabovementionedweremaininfluencefactorsinthepatientswith1ivermetastasestreatedbyregionaltherapyofhepatiCartery[Keywords]Livermetastasis：Regionaltherapy：Hepaticartery：Treatmente